CLOVER HEALTH INVESTMENTS, CORP. /DE 8-K

What Happened

• Clover Health Investments, Corp. (CLOV) filed an 8-K on Jan. 14, 2026 disclosing two items: CEO Andrew Toy will present at the 43rd Annual J.P. Morgan Healthcare Conference on Jan. 15, 2026 at 11:15 a.m. ET (a live webcast and slide deck will be available via the company’s investor relations site), and the company issued a press release with preliminary Medicare Advantage Annual Election Period (AEP) results on Jan. 14, 2026.

Key Details

• CEO Andrew Toy presentation: Jan. 15, 2026 at 11:15 a.m. Eastern Time; webcast available on Clover Health’s investor relations page; slide presentation attached to the filing.
• Preliminary AEP results: Announced via a Jan. 14, 2026 press release (included as an exhibit to the 8-K).
• Form 8-K filed under Regulation FD disclosure (Item 7.01) and lists the press release and slide deck as exhibits.

Why It Matters

• The CEO’s JP Morgan presentation is a near-term event where management may discuss strategy, business trends, and recent results; investors can watch the webcast and review slides for direct commentary from leadership.
• Preliminary Medicare Advantage AEP results give early enrollment signals for Clover’s core business (Medicare Advantage), which can affect revenue and growth expectations once finalized. Investors should review the detailed AEP release and listen to the presentation for further context.